Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia.
Ann Hematol
; 98(11): 2569-2578, 2019 Nov.
Article
in En
| MEDLINE
| ID: mdl-31628518
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Plasma Cell
/
Isoquinolines
/
Multiple Myeloma
/
Antineoplastic Agents
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Aged
/
Animals
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Hematol
Journal subject:
HEMATOLOGIA
Year:
2019
Document type:
Article
Affiliation country:
Austria
Country of publication:
Alemania